id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-263556-y8vx4ie2	Koistinen, Annamari	Prednisolone for the first rhinovirus‐induced wheezing and 4‐year asthma risk: A randomized trial	2017-08-06		.txt	text/plain	2996	184	53	Based on our previous findings, 8, 9 we hypothesized that in children with high rhinovirus genome load, the effect of OCS is likely to last beyond 12 months by reducing the need for initiation of long-term asthma control medication. Second, in the placebo group, asthma risk was high: regular asthma control medication was initiated to all children with high rhinovirus genome load during the subsequent 14 months after the first acute rhinovirus-induced wheezing episode. No difference was found in overall analysis F I G U R E 3 The time to initiation of asthma control medication in children randomized to receive prednisolone or placebo for the first rhinovirus-induced wheezing episode. 9 In summary, early systemic short-course prednisolone treatment may be beneficial in reducing the risk for asthma control medication during the first 5 years in first-time wheezing preschool children whose episode was severe and associated with high rhinovirus genome load.	./cache/cord-263556-y8vx4ie2.txt	./txt/cord-263556-y8vx4ie2.txt